M&A Deal Summary |
|
---|---|
Date | 2016-01-07 |
Target | Trividia Health |
Sector | Medical Products |
Buyer(s) | Sinocare |
Sellers(s) | Nipro |
Deal Type | Divestiture |
Deal Value | 273M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2002 |
Sector | Medical Products |
Employees | 4,531 |
Revenue | 4.1B CNY (2023) |
Sinocare is a developer of biosensor technology. The Company promotes diabetic self-management by using blood glucose monitoring systems, providing total diabetes services and solutions. Sinocare Group was founded in 2002 and is based in Changsha, China.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Medical Products) | 1 of 2 |
Type (Divestiture) | 1 of 1 |
State (Florida) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2016) | 1 of 2 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-05-02 |
PTS Diagnostics
Whitestown, Indiana, United States PTS Diagnostics designs, manufactures, distributes and markets products for distribution. PTS Diagnostics is an innovative, global, point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decision. PTS Diagnostics was founded in 1992 and is based in Whitestown, Indiana. |
Buy | $200M |
Category | Company |
---|---|
Founded | 1947 |
Sector | Medical Products |
Employees | 38,117 |
Revenue | 586.8B JPY (2024) |
Nipro is engaged directly and through its subsidiaries principally in the development, manufacture and sale of medical devices, pharmaceutical products and medical and glass products. Nipro’s medical device division is engaged in the manufacture and sale of medical devices and its related products, the development, manufacture and sale of cell culturing-related products, as well as the development and sale of diabetes-related products. Nipro was founded in 1947 and is based in Osaka, Japan.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Medical Products) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
State (Florida) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2016) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-09-11 |
Infraredx
Burlington, Massachusetts, United States Infraredx, Inc. is an intravascular medical device company committed to advancing the diagnosis and management of coronary artery disease globally. |
Buy | - |